滑液D-乳酸:一种用于假体周围关节感染诊断的新型病原体特异性生物标志物
该前瞻性诊断研究纳入224例在假体翻修前接受关节穿刺的患者,评估滑液D-乳酸诊断假体周围关节感染(PJI)的性能。使用MSIS标准时,最佳cutoff为1.3 mmol/L,灵敏度94.3%、特异度78.4%;使用机构标准时灵敏度92.4%、特异度88.6%。D-乳酸浓度在金黄色葡萄球菌和链球菌感染中高于凝固酶阴性葡萄球菌感染或培养阴性PJI。
要点
- 滑液D-乳酸诊断PJI的最佳cutoff为1.3 mmol/L,不依赖于所用定义标准。
- 使用MSIS标准时灵敏度94.3%(95%CI 86.2-98.4),特异度78.4%(95%CI 66.8-81.2)。
- D-乳酸浓度与病原体毒力相关,金黄色葡萄球菌和链球菌感染中更高。
核心结论
- 滑液D-乳酸在两种定义标准下诊断PJI的灵敏度均超过90%,可作为PJI的即时筛查试验。
研究设计与样本
- 前瞻性纳入连续在假体翻修前接受关节穿刺的患者,采集滑液进行培养、白细胞计数和D-乳酸浓度测定(分光光度法)。
- 共纳入224例患者,使用Musculoskeletal Infection Society(MSIS)标准诊断PJI 71例(32%)、无菌性失败153例(68%);使用机构标准诊断PJI 92例(41%)、无菌性失败132例(59%)。
- 采用Youden J统计量在受试者工作特征曲线上确定D-乳酸最佳cutoff值,以最大化灵敏度和特异度。
主要发现
- 滑液D-乳酸鉴别PJI与无菌性失败的最佳cutoff为1.3 mmol/L,独立于所用定义标准。
- 使用MSIS标准时,D-乳酸灵敏度94.3%(95%CI 86.2-98.4),特异度78.4%(95%CI 66.8-81.2)。
- 使用机构标准时,D-乳酸灵敏度92.4%(95%CI 84.9-96.9),特异度88.6%(95%CI 81.9-93.5)。
- D-乳酸浓度在金黄色葡萄球菌感染(P < .001)和链球菌感染(P = .016)中高于凝固酶阴性葡萄球菌感染或培养阴性PJI。
关键数值与推荐
- PJI诊断定义标准:MSIS标准和机构标准,具体条款原文未详述。
- D-乳酸最佳cutoff值为1.3 mmol/L。
- MSIS标准下灵敏度94.3%(95%CI 86.2-98.4)、特异度78.4%(95%CI 66.8-81.2)。
- 机构标准下灵敏度92.4%(95%CI 84.9-96.9)、特异度88.6%(95%CI 81.9-93.5)。
临床怎么用
- 滑液D-乳酸因高灵敏度(>90%)可作为PJI的即时筛查试验,最佳cutoff为1.3 mmol/L。
- D-乳酸浓度与病原体毒力相关,金黄色葡萄球菌和链球菌感染中浓度更高,可辅助判断病原体类型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Synovial fluid d-lactate may be useful for diagnosing periprosthetic joint infection (PJI) as this biomarker is exclusively produced by bacteria. We evaluated the performance of synovial fluid d-lactate using 2 definition criteria and determined its optimal cutoff value for diagnosing PJI. METHODS: Consecutive patients undergoing joint aspiration before prosthesis revision were prospectively included. Synovial fluid was collected for culture, leukocyte count, and d-lactate concentration (by spectrophotometry). Youden's J statistic was used for determining optimal d-lactate cutoff value on the receiver operating characteristic curve by maximizing sensitivity and specificity. RESULTS: A total of 224 patients were included. Using Musculoskeletal Infection Society criteria, 71 patients (32%) were diagnosed with PJI and 153 (68%) with aseptic failure (AF), whereas using institutional criteria, 92 patients (41%) were diagnosed with PJI and 132 (59%) with AF. The optimal cutoff of synovial fluid d-lactate to differentiate PJI from AF was 1.3 mmol/L, independent of the used definition criteria. Synovial fluid d-lactate had a sensitivity of 94.3% (95% confidence interval [95% CI], 86.2-98.4) and specificity of 78.4% (95% CI, 66.8-81.2) using Musculoskeletal Infection Society criteria, whereas its sensitivity was 92.4% (95% CI, 84.9-96.9) and specificity 88.6% (95% CI, 81.9-93.5) using institutional criteria. The concentration of d-lactate was higher in infections caused by Staphylococcus aureus (P < .001) and streptococci (P = .016) than by coagulase-negative staphylococci or in culture-negative PJI. CONCLUSION: The synovial fluid d-lactate showed high sensitivity (>90%) for diagnosis of PJI using both definition criteria and correlated with the pathogen virulence. The high sensitivity makes this biomarker useful as a point-of-care screening test for PJI. LEVEL OF EVIDENCE: Diagnostic level I.
引用
- Karbysheva S, Yermak K, Grigoricheva L, et al. Synovial Fluid d-Lactate-A Novel Pathogen-Specific Biomarker for the Diagnosis of Periprosthetic Joint Infection. J Arthroplasty. 2020. PMID: 32269008. doi:10.1016/j.arth.2020.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。